The Outcome of Surgical and Radiotherapy in Central Neurocytoma: A Case Report: The Outcome of Surgical and Radiotherapy in Central Neurocytoma: A Case Report

Rahmi  Ardhini; Krisna  Tsaniadi Prihastomo; Dion  Firli Bramantyo; Dodik  Tugasworo; Retnaningsih Retnaningsih; Yovita Andhitara Andhitara; Aditya Kurnianto Kurnianto; Jethro Budiman

doi:10.36408/mhjcm.v9i3.554

Authors

Rahmi Ardhini Department of Neurology, Dokter. Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Krisna Tsaniadi Prihastomo Department of Neurosurgery, Dokter Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Dion Firli Bramantyo Department of Radiation Oncology, Dokter Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Dodik Tugasworo Department of Neurology, Dokter. Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Retnaningsih Department of Neurology, Dokter. Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Yovita Andhitara Department of Neurology, Dokter. Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Aditya Kurnianto Department of Neurology, Dokter. Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
Jethro Budiman Department of Neurology, Dokter. Kariadi Hospital/Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia

DOI:

https://doi.org/10.36408/mhjcm.v9i3.554

Keywords:

central neurocytoma, hydrocephalus, neuro-epethelial tumor, radiotherapy

Abstract

BACKGROUND: Central neurocytoma (CN) is an infrequent and non-malignant neuro-epithelial tumor. CN is mostly found in lateral ventricle and may generate obstructive hydrocephalus. Surgical-radiation can increase patient survival and prognosis. This case report presented a rare case about 30-year-old female with CN.

CASE PRESENTATION: 30-year-old female came to the hospital with severe headache and vomiting. Brain MRI showed a heterogeneous mass in right lateral ventricle causing obstructive hydrocephalus. The patient undergone partial resection. CN confirmed from histopathological analysis. Afterward, patient received 54 Gy conventional radiotherapy. 3 months after radiation, patient remain asymptomatic and no neurological deficit. Brain MRI evaluation showed slightly reduction of tumor mass (from 4,09 x 3,01 x 4,13 cm before radiation to 4,00 x 3,86 x 3,63 cm after radiation).

DISCUSSION: This case report was consistent clinically, radiologically, and histopathologically with intraventricular CN. Headache and vomiting in patient due to the raised intracranial pressure from tumor mass and obstructive hydrocephalus. Headache is a significant and most frequent symptom in intraventricular tumors, may be caused by traction or compression of the pain-sensitive structures such as meningen and intracranial vasculature. Optimal management of CN still remains controversial due to their rarity. However, surgical management with gross total resection is the gold standard of treatment modality, associated with good prognosis and longer progression-free survival.

CONCLUSION: Based on clinical characteristic, radiographic finding and histopathological features; this case was consistent with CN of the lateral ventricle. Surgical as the treatment option followed by radiation has led to good clinical outcome in this patient.

KEYWORDS: central neurocytoma, hydrocephalus, neuro-epethelial tumor, radiotherapy

Downloads

Download data is not yet available.

References

Soffietti R, Duffau H, Bauman G, Walker D. Neuronal and mixed neuronal-glial tumours. In: Batchelor T, Nishikawa R, Tarbell N, Weller M, Editors. Oxford textbook of neuro-oncology. Oxford: Oxford university press; 2017; 201-5.

Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G, Pellissier JF, Toga M. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol. 1982; 56(2):151-6.

Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131:803-20.

Lee SJ, Bui TT, Chen CHJ, Lagman C, Chung LK, Sidhu S, et al. central Neurocytoma: a review of clinical management and histopathologic features. Brain Tumor Res Treat. 2016; 4(2):49-57

Schramm J, Kristoff R. Glioneuronal tumors. In: Tonn JC, Westphal M, Rutka JT, Grossman SA, Editors. Neurooncology of CNS tumor. Germany: Springer-Verlag; 2006: 167-80.

Dutta SW, Kaleem TA, Muller DA, Peterson J, Harrell AC, Quinones-Hinojosa A, et al. Central neurocytoma: Clinical characteristics, patterns of care and survival. Journal of Clinical Neuroscience. 2018: 106-11.

Yang I, Ung N, Chung LK, Nagasawa DT, Thill K, Park J, Tenn S. Clinical manifestation of central neurocytoma. Neurosurg Clin N Am. 2015; 26(1):5-10

Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N, Weinberg VK, et al. Clinical outcome and prognostic factors for central neurocytoma: twenty-year institutional experience. J Neurooncol. 2016; 126(1):193-200.

Patel DM, Schmidt RF, Liu JK. Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci. 2013; 20:1193-9.

Kim JW, Kim DG, Kim IK, et al. Central neurocytoma: Long-term outcomes of multimodal treatments and management strategies based on 30 years-experience in a single institute. Neurosurgery. 2013; 72(3):407-14.

Ranjan S, Schiff D. headache as complication of cancer. In: Schiff D, Arrillaga I, Wen PY, Editors. Cancer neurology in clinical practice. 3rd Ed. Springer International publishing. 2018: 143-52.

Schild SE, Scheithauer BW, Haddock MG, et al. Central neurocytomas. Cancer. 1997; 79:790-5.

Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW. Central neurocytoma: a review. J Neurooncol. 2004; 66:377-84.

Kashiwazaki D, Takaiwa A, Nagai S, Akioka N, Kurosaki K, Noguchi K, et al. Reversal of cognitive dysfunction by total removal of a large lateral ventricle meningioma: a case report with neuropsychological assessments. Case rep neurol. 2014; 6:44-9.

Li Y, Ye XF, Qian G, Yin Y, Pan QG. Pathologic features and clinical outcome of central neurocytoma: analysis of 15 cases. Chinese J of Cancer Res. 2012; 24(4):284-90.

Soylemezoglu F, Onder S, Tezel GG, Berker M. Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. Pathol Res Pract. 2003; 199:463-8.

Rades D, Fehlauer F. Treatment options for central neurocytoma. Neurology. 2002; 59(8):1268–70.

Paek SH, Han JH, Kim JW, Park CK, Jung HW, Park SH, et al. Long-term outcome of conventional radiation therapy for central neurocytoma. J Neurooncol. 2008; 90:25-30.

Johnson MO, Kirkpatrick JP, Patel MP, Desjardins A, Randazzo DM, Friedman HS, et al. The role of chemotherapy in the treatment of central neurocytoma. CNS Oncol. 2019; 8(3).

Kulkarni V, Rajshekhar V, Haran RP, Chandi SM. Long-term outcome in patients with central neurocytoma following stereotactic biopsy and radiation therapy. Br. J. Neurosurg. 2002; 16(2): 126-32.

Marri M, Ahmad I, Ahmad K, Ashfaq Z. central neurocytoma of the third ventricle: case report and treatment. Egyptian J of basic and applied sciences. 2017: 361-5.

Chen YD et al. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma. Radiat Oncol 2014; 9:242.

The Outcome of Surgical and Radiotherapy in Central Neurocytoma: A Case Report